Posted by Michael Wonder on 07 Mar 2022
Novavax’s Covid-19 vaccine moves closer to FDA authorisation decision
6 March 2022 - Company says it has resolved manufacturing problems that led to earlier delays; FDA is reviewing shot’s authorisation application.
Clearance in the U.S. isn’t imminent because the FDA must sort through a large amount of study data from several countries, a person familiar with the matter said.
